Evaluation of a Nutritional Technology for Vitamin D Absorption
Completed · Not applicable
Conditions studied: Nutrition, Healthy
In brief
This is a prospective, 2-group crossover, randomized, double-blind study to evaluate nutrient absorption.
Key facts
- Study ID
- NCT06266702
- Run by
- Abbott Nutrition
- People needed
- 26
- Starts
- 2024-03-15
- Expected to finish
- 2024-05-02
- Last updated by the study team
- 2024-07-31
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adult participants (18-55 years of age)
- Body mass index (BMI) <30 kg/m2
- Males and nonpregnant, nonlactating females
- Free of gastrointestinal disorders that my impact nutrient absorption in the small intestine, endocrine, hepatic, renal, or bone diseases
You may not qualify if…
- Use of vitamin D or calcium supplements within 3 weeks prior to the Screening Visit.
- Use of a tanning booth/lamp within 3 weeks prior to the Screening Visit.
- Travel to sunny location within 3 weeks prior to the Screening Visit.
- Consumption of more than 3 alcoholic drinks per day starting 48 hours before the Screening Visit.
- Has an allergy or intolerance to any ingredient in the study product.
- Participating in another study that has not been approved as a concomitant study by Abbott Nutrition.
- Use of the following medications that may have interactions with vitamin D absorption or metabolism:
- Aluminum-containing phosphate binders
- Anticonvulsants
- Atorvastatin
- Calcipotriene
- Cholestyramine
- Cytochrome P-450 3A4 substrates
- Digoxin
- Diltiazem
- Orlistat
- Thiazide diuretics
- Corticosteroids
- Stimulant laxatives
- Verapamil
Where it is running
- Walsh University — North Canton, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.